August 22, 2024

2 Minutes
Medicine

Everest Medicines announces Investigator-Initiated Clinical Trial for cancer vaccine programme

Everest Medicines has announced the launch of an Investigator-Initiated Clinical Trial (IIT) for a personalised mRNA cancer vaccine, EVM16, under the study EVM16CX01, at the Peking University Cancer Hospital and Fudan University’s Cancer Hospital....
Read More